We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Johnson Matthey Plc | LSE:JMAT | London | Ordinary Share | GB00BZ4BQC70 | ORD 110 49/53P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 5.00 | 0.29% | 1,747.00 | 1,742.00 | 1,744.00 | 1,763.00 | 1,735.00 | 1,763.00 | 286,503 | 16:35:07 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Chemicals & Chem Preps, Nec | 14.97B | 276M | 1.5064 | 11.56 | 3.19B |
From Apr 2019 to Apr 2024
TIDMJMAT
RNS Number : 4465G
Johnson Matthey PLC
02 March 2018
Johnson Matthey appointment of Sector Chief Executive, Health
Johnson Matthey is pleased to announce the appointment of Jason Apter as Sector Chief Executive, Health. He will join Johnson Matthey on 5(th) March and be based in the US.
Jason brings deep experience of the healthcare and life sciences industries where he has held executive positions in both the US and Asia. In his most recent role Jason was the Executive Vice President, Research Solutions of MilliporeSigma, the life sciences arm of Merck KGaA, and was based in the US. Prior to that Jason was Vice President and Managing Director, Asia Pacific for the Sigma-Aldrich Corporation, based in Singapore.
Jason was educated in Canada and received his MBA from Duke University USA.
Robert MacLeod, Chief Executive, Johnson Matthey commented "I am delighted to welcome Jason to Johnson Matthey as Sector Chief Executive, Health. His experience in global life sciences businesses will be invaluable in further building our pipeline of products and bringing these to market, enabling us to grow our Health business and deliver on our strategy."
Enquiries:
Analysts and investors:
Martin Dunwoodie +44 (0)20 7269 8241 Simon McGough +44 (0)20 7269 8235 Katharine Burrow +44 (0)20 7269 8444
Media:
Sally Jones +44 (0)20 7269 8407
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLLFFEVAILIIT
(END) Dow Jones Newswires
March 02, 2018 02:00 ET (07:00 GMT)
1 Year Johnson Matthey Chart |
1 Month Johnson Matthey Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
